Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Ind-Swift Laboratories Ltd. ( (IN:INDSWFTLAB) ) is now available.
Ind-Swift Laboratories Ltd. has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending June 30, 2025. This certificate confirms that the company’s equity share certificates have been listed on stock exchanges, verified, mutilated, and canceled, with the depository’s name updated as the registered owner, ensuring compliance and transparency in their operations.
More about Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its commitment to quality and innovation, serving both domestic and international markets.
Average Trading Volume: 40,600
Current Market Cap: 6.78B INR
For an in-depth examination of INDSWFTLAB stock, go to TipRanks’ Overview page.